Final analysis shows Coronavirus vaccine is 95% effective


Julia Salas, Freshman

Many people have been anticipating the arrival of the COVID-19 vaccine. This is one of the few ways to stop the spread of the virus.

Working towards creating a safe and effective vaccine is a top priority to move forward with this pandemic. The pharmaceuticals said on Friday, November 20, 2020, that they had applied to the Food and Drug Administration (FDA), to authorize the coronavirus vaccine for emergency use. 

Submitting emergency use authorization (EUA) applications move a potential COVID-19 vaccine one step closer to patients, and experts say Americans can start receiving shots by the end of December.

The release of a COVID-19 vaccine is a very urgent manner. However, health officials, vaccine manufacturers and the FDA have committed to only putting out vaccines that are proven to be safe. 

In order to help the rest of the world with the American updates on the vaccine, big pharma is sharing their results.  Pfizer, one of the pharmaceutical companies announced, “This data will also be submitted to other regulatory agencies around the world.” 

Generally, the path of a vaccine from a laboratory to a person’s immune system takes years to navigate. The speed at which manufacturers and regulators have moved this year is unprecedented.

“We are covering new territory. This has never been done before,” said Norman Baylor, president and chief executive of Biologics consulting and former director of the Food and Drug Administrations Office of Vaccine Research and Review. 

Hopefully experts find a way to cure people who have been affected by COVID-19 or help people create immunity to the virus, before the numbers increase even more.